Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults. (Q51752825)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 April 2007

Language	Label	Description	Also known as
English	Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults.	scientific article published on 26 April 2007

Statements

scholarly article

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults. (English)

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

pneumococcal vaccine

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

author name string

Ian F Cook

1

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

Dimity Pond

2

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

language of work or name

0 references

publication date

26 April 2007

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

25

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

25

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

4767-4774

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Pneumonia in old age; active immunization against pneumonia with pneumonococcus polysaccharide; results of a six year study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: another view of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Review of pneumococcal conjugate vaccine in adults: implications on clinical development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Pneumococcal vaccines: an update on current strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Definition of needle length required for intramuscular deltoid injection in elderly adults: an ultrasonographic study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Comparative reactogenicity and parental acceptability of pertussis vaccines administered into the ventrogluteal area and anterolateral thigh in children aged 2, 4, 6 and 18 months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Pneumococcal infection and vaccination in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Simultaneous influenza and pneumococcal vaccination in elderly individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Safety of revaccination with pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Pneumococcal polysaccharide revaccination: immunoglobulin g seroconversion, persistence, and safety in frail, chronically ill older subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Reactions after pneumococcal vaccine alone or in combination with influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

The importance of injecting vaccines into muscle. Different patients need different needle sizes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.04.017

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

1 reference

Europe PubMed Central

11 April 2018

http://europepmc.org/abstract/MED/17512098

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51752825&oldid=1565374754"